EUVIMEDEUVIMED entdecken
Crossref

Amyloid deposition in adults with drug‐resistant temporal lobe epilepsy

Elena Fonseca iD, Sofía Lallana iD, Gemma Ortega iD, Amanda Cano iD, Silvana Sarria-Estrada iD, Deborah Pareto iD, Manuel Quintana iD, Carles Lorenzo-Bosquet iD, Samuel López-Maza iD, Ariadna Gifreu iD, Daniel Campos-Fernández iD, Laura Abraira iD und 13 weitere

Epilepsia · 2024

DOI: 10.1111/epi.18142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Elena Fonseca und 24 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Unit, Neurology Department, Medicine Department, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Vall d'Hebron Barcelo…. Hauptthemen laut MEDLINE: Epilepsy, Temporal Lobe, Amyloid beta-Peptides, Positron-Emission Tomography, Drug Resistant Epilepsy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Pathological amyloid‐β (Aβ) accumulation and hyperphosphorylated tau proteins have been described in resected temporal lobe specimens of epilepsy patients. We aimed to determine cerebrospinal fluid (CSF) Aβ1‐42 and p181‐tau levels and cerebral Aβ deposits on positron emission tomography (Aβ PET) and correlate these findings with cognitive performance in adults with drug‐resistant temporal lobe epilepsy (TLE).

Methods

In this cross‐sectional study, we enrolled individuals with drug‐resistant TLE who were 25–55 years old. Each participant underwent 18 F‐flutemetamol PET, determination of CSF Aβ1‐42, p181‐tau, and total tau, and a comprehensive neuropsychological assessment. We evaluated normalized standard uptake value ratios (SUVRs) for different brain regions on Aβ PET.

Results

Thirty patients (mean age = 41.9 ± SD 8.1 years, 57% men) were included. The median disease duration was 9.5 (interquartile range = 4–24) years. Twenty‐six patients (87%) had a clinically significant cognitive impairment on neuropsychological evaluation, 18 (69%) of the amnesic type. On Aβ PET, high uptake was observed in both mesial temporal regions (ipsilateral: SUVR z ‐score = .90, 95% confidence interval [CI] = .60–1.20; contralateral: SUVR z ‐score = .92, 95% CI = .57–1.27; p < .001), which was higher when compared to SUVR z ‐scores in all the remaining regions ( p < .001) and in the ipsilateral anterior cingulate (SUVR z ‐score = .27, 95% CI = .04–.49, p = .020). No significant deposition was observed in other regions. Seven patients (23%) had low Aβ1‐42 levels, and two (7%) had elevated p181‐tau levels in CSF. Higher p181‐tau levels correlated with poorer verbal fluency ( R = −.427, p = .044). Significance Our findings reveal a considerable Aβ deposition in mesial temporal regions and ipsilateral anterior cingulate among adults with drug‐resistant TLE. Additionally, abnormal CSF Aβ1‐42 levels were observed in a significant proportion of patients, and p181‐tau levels were associated with verbal fluency. These results suggest that markers of neuronal damage can be observed in adults with TLE, warranting further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, Temporal LobeAmyloid beta-PeptidesPositron-Emission TomographyDrug Resistant Epilepsytau ProteinsPeptide FragmentsHumansMaleFemaleAdultMiddle AgedCross-Sectional StudiesNeuropsychological TestsAniline CompoundsBenzothiazoles

Stichwörter der Autor:innen

amyloid positron emission tomographycognitive impairmenttemporal lobe epilepsy

Substanzen

Amyloid beta-Peptidestau ProteinsPeptide Fragmentsamyloid beta-protein (1-42)flutemetamolAniline CompoundsBenzothiazoles

Autor:innen und Institutionen

  • Epilepsy Unit, Neurology Department, Medicine Department, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Research Group on Status Epilepticus and Acute Seizures, Vall d'Hebron Research Institute, Vall d'Hebron University Hospital, Vall d'Hebron Hospital Campus, Barcelona, Spain.
  • Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Network Center for Biomedical Research in Neurodegenerative Diseases, Instituto de Salud Carlos III, Madrid, Spain.
  • Neuroradiology Section, Radiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Nuclear Medicine Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

ORCID-Profile: Elena Fonseca, Sofía Lallana, Gemma Ortega, Amanda Cano, Silvana Sarria-Estrada, Deborah Pareto, Manuel Quintana, Carles Lorenzo-Bosquet, Samuel López-Maza, Ariadna Gifreu, Daniel Campos-Fernández, Laura Abraira, Estevo Santamarina, Adelina Orellana, Laura Montrreal, Raquel Puerta, Itziar de Rojas, Agustín Ruiz, Lluis Tárraga, Àlex Rovira, Marta Marquié, Mercè Boada, Manuel Toledo

Zitieren

APA

Fonseca, E., Lallana, S., Ortega, G., Cano, A., Sarria-Estrada, S., Pareto, D., Quintana, M., Lorenzo-Bosquet, C., López-Maza, S., Gifreu, A., Campos-Fernández, D., Abraira, L., Santamarina, E., Orellana, A., Montrreal, L., Puerta, R., Aguilera, N., Ramis, M., de Rojas, I., …, & Toledo, M. (2024). Amyloid deposition in adults with drug‐resistant temporal lobe epilepsy. Epilepsia. https://doi.org/10.1111/epi.18142

Vancouver

Fonseca E, Lallana S, Ortega G, Cano A, Sarria-Estrada S, Pareto D, et al. Amyloid deposition in adults with drug‐resistant temporal lobe epilepsy. Epilepsia. 2024. doi:10.1111/epi.18142

BibTeX
@article{Fonseca2024,
  author = {Fonseca, Elena and Lallana, Sofía and Ortega, Gemma and Cano, Amanda and Sarria-Estrada, Silvana and Pareto, Deborah and Quintana, Manuel and Lorenzo-Bosquet, Carles and López-Maza, Samuel and Gifreu, Ariadna and Campos-Fernández, Daniel and Abraira, Laura and Santamarina, Estevo and Orellana, Adelina and Montrreal, Laura and Puerta, Raquel and Aguilera, Núria and Ramis, Maribel and de Rojas, Itziar and Ruiz, Agustín and Tárraga, Lluis and Rovira, Àlex and Marquié, Marta and Boada, Mercè and Toledo, Manuel},
  title = {Amyloid deposition in adults with drug‐resistant temporal lobe epilepsy},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.18142}
}
Kostenlos starten →